Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-07
2007-08-07
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S275000, C544S323000, C544S324000, C544S326000, C544S328000, C544S329000
Reexamination Certificate
active
11485075
ABSTRACT:
N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula (I):Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-α expression utilizing compounds of the present invention are also disclosed.
REFERENCES:
patent: 5428044 (1995-06-01), Bantick et al.
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6342503 (2002-01-01), Aldrich et al.
patent: WO01/19825 (2001-03-01), None
patent: WO01/27089 (2001-04-01), None
patent: WO01/28561 (2001-04-01), None
patent: WO01/47897 (2001-07-01), None
patent: WO 01/72717 (2001-10-01), None
patent: WO03/002542 (2003-01-01), None
patent: WO03/032994 (2003-04-01), None
patent: WO03/032997 (2003-04-01), None
patent: WO03/063794 (2003-08-01), None
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Vippagunta et al., Cyrstalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Database Caplus, Accession No. 104:168491, JP61-10563 B (Ito et al.) Jan. 18, 1986 see CAS abstract.
Wissner et al., J. Med. Chem. 2000, 43, pp. 3244-3256.
Chen et al., Biochemistry 1998, 37, p. 17735-17744.
Ahmed Gulzar
Diller David J.
Henderson Ian
Leftheris Katerina
Liu Chunjian
Bristol--Myers Squibb Company
O'Brien Maureen P.
Pharmacopeia Inc.
Rao Deepak
Wang Joseph C.
LandOfFree
N-heterocyclic inhibitors of TNF-α expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-heterocyclic inhibitors of TNF-α expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-heterocyclic inhibitors of TNF-α expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3900536